Tag: asset
Evommune ends development of lead asset in chronic hives after mid-stage efficacy woes – BioSpace
eczemarelief
June 30, 2026
Quoin Pharmaceuticals Extends Exclusive Distribution Agreement with ER-Kim for its Lead Asset, QRX003, for Netherton Syndrome
eczemarelief
March 1, 2022
Quoin Pharmaceuticals Signs Exclusive Distribution Agreement with Neopharm for its Lead Asset, QRX003, for Netherton Syndrome
eczemarelief
February 17, 2022